Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q1 FY25 results · Apr–Jun 2024
Amrutanjan Health Care reported revenue from operations of ₹83.74 crore (up 7.5% from Q1 FY24) and net profit of ₹4.62 crore (down 34.2% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a standalone basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 83.74 | 77.86 | +7.5% | 127.06 | −34.1% |
| Other income | 4.45 | 3.69 | +20.8% | 5.54 | −19.7% |
| Total income | 88.19 | 81.55 | +8.1% | 132.61 | −33.5% |
| Profit before tax | 6.35 | 9.43 | −32.7% | 19.60 | −67.6% |
| Net profit for the period | 4.62 | 7.01 | −34.2% | 13.66 | −66.2% |
| EPS, basic (₹) | 1.60 | 2.40 | −33.3% | 4.72 | −66.1% |
| Net margin (%) | 5.5 | 9.0 | 10.7 |
Standalone
- Filed with BSE
- 27 Aug 2024, 14:31 IST
- Board meeting
- 13 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE